IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Decheng Capital LLC

Q4 2023 Holdings

Filed 2024-02-12 | 24 holdings | $357.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Alpine Immune Sciences, Inc.(NVLSEUR)COM02083G100$135.0M7,083,28837.7%
Zentalis Pharmaceuticals Inc.(ZNTL)COM98943L107$31.8M2,099,5838.9%
Pacific Biosciences of California, Inc.(PACB)COM69404D108$28.8M2,940,3618.1%
10x Genomics, Inc.(TXG)CL A COM88025U109$20.1M359,5545.6%
Immunogen Inc(IMGNEUR)COM45253H101$19.6M659,9285.5%
Arcus Biosciences, Inc(RCUS)COM03969F109$16.6M869,7904.6%
Karuna Therapeutics IncCOM48576A100$14.9M47,0004.2%
Roivant Sciences LTD(ROIV)COMG76279101$14.4M1,279,7004.0%
Illumnia, Inc.(ILMN)COM452327109$11.3M80,8593.1%
Argenx SE(ARGX)SHS04016X101$10.4M27,4292.9%
Acelyrin Inc(nsm)COM00445A100$10.2M1,370,9512.9%
Krystal Biotech Inc(KRYS)COM501147102$8.2M65,7722.3%
Phathom Pharmaceuticals Inc(PHAT)COM71722W107$7.8M850,0002.2%
Lantheus Holdings Inc(nms)(LNTH)COM516544103$5.7M92,1961.6%
Terns Pharmaceuticals, Inc.(TERN)COM880881107$4.6M714,2851.3%
Aura Biosciences, Inc.(AURA)COM05153U107$4.6M515,5551.3%
BeyondSpring Inc.(BYSI)SHSG10830100$4.5M4,958,1431.2%
Equillium Inc.(EQ)COM29446K106$3.2M4,447,3080.9%
AtriCure Inc.(ATRC)COM04963C209$1.7M46,2590.5%
Cue Health Inc.(HLTHQ)COM229790100$1.5M8,980,9090.4%
Scynexis Inc.(SCYX)COM NEW811292200$1.2M555,5550.3%
Aadi Bioscience, Inc.(WHWK)COM00032Q104$1.1M526,3290.3%
Pyxis Oncology, Inc (formerly Apexigen)(PYXS)COM747324101$588.3K326,8100.2%
GeneDx Holdings Corp.(WGS)COM CL A81663L200$284.9K103,6040.1%